Literature DB >> 26940928

Gaps in Adherence to Guideline-Directed Medical Therapy Before Defibrillator Implantation.

Gregg C Fonarow1, Boback Ziaeian2.   

Abstract

Entities:  

Keywords:  adrenergic beta-antagonists; angiotensin-converting enzyme inhibitors; guideline adherence; heart failure; implantable cardioverter defibrillator

Mesh：

Year:  2016        PMID： 26940928      PMCID： PMC4818118          DOI： 10.1016/j.jacc.2015.12.045

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  20 in total

1.  Optimal medical therapy use among patients receiving implantable cardioverter/defibrillators: insights from the National Cardiovascular Data Registry.

Authors:  Amy Leigh Miller; Yongfei Wang; Jeptha Curtis; Frederick A Masoudi; Alfred E Buxton; Tracy Y Wang
Journal:  Arch Intern Med       Date:  2011-11-14

2.  Medicare Part D enrollees' use of out-of-plan discounted generic drugs.

Authors:  Bruce Stuart; F Ellen Loh; Ellen F Loh
Journal:  J Am Geriatr Soc       Date:  2012-02       Impact factor: 5.562

3.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Mark H Drazner; Gregg C Fonarow; Stephen A Geraci; Tamara Horwich; James L Januzzi; Maryl R Johnson; Edward K Kasper; Wayne C Levy; Frederick A Masoudi; Patrick E McBride; John J V McMurray; Judith E Mitchell; Pamela N Peterson; Barbara Riegel; Flora Sam; Lynne W Stevenson; W H Wilson Tang; Emily J Tsai; Bruce L Wilkoff
Journal:  J Am Coll Cardiol       Date:  2013-06-05       Impact factor: 24.094

4.  ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons.

Authors:  Andrew E Epstein; John P DiMarco; Kenneth A Ellenbogen; N A Mark Estes; Roger A Freedman; Leonard S Gettes; A Marc Gillinov; Gabriel Gregoratos; Stephen C Hammill; David L Hayes; Mark A Hlatky; L Kristin Newby; Richard L Page; Mark H Schoenfeld; Michael J Silka; Lynne Warner Stevenson; Michael O Sweeney; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Christopher E Buller; Mark A Creager; Steven M Ettinger; David P Faxon; Jonathan L Halperin; Loren F Hiratzka; Sharon A Hunt; Harlan M Krumholz; Frederick G Kushner; Bruce W Lytle; Rick A Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Lynn G Tarkington; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2008-05-27       Impact factor: 24.094

5.  Clinical and demographic predictors of outcomes in recent onset dilated cardiomyopathy: results of the IMAC (Intervention in Myocarditis and Acute Cardiomyopathy)-2 study.

Authors:  Dennis M McNamara; Randall C Starling; Leslie T Cooper; John P Boehmer; Paul J Mather; Karen M Janosko; John Gorcsan; Kevin E Kip; G William Dec
Journal:  J Am Coll Cardiol       Date:  2011-09-06       Impact factor: 24.094

6.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Authors:  Gust H Bardy; Kerry L Lee; Daniel B Mark; Jeanne E Poole; Douglas L Packer; Robin Boineau; Michael Domanski; Charles Troutman; Jill Anderson; George Johnson; Steven E McNulty; Nancy Clapp-Channing; Linda D Davidson-Ray; Elizabeth S Fraulo; Daniel P Fishbein; Richard M Luceri; John H Ip
Journal:  N Engl J Med       Date:  2005-01-20       Impact factor: 91.245

Review 7.  Potential impact of optimal implementation of evidence-based heart failure therapies on mortality.

Authors:  Gregg C Fonarow; Clyde W Yancy; Adrian F Hernandez; Eric D Peterson; John A Spertus; Paul A Heidenreich
Journal:  Am Heart J       Date:  2011-06       Impact factor: 4.749

8.  HFSA 2010 Comprehensive Heart Failure Practice Guideline.

Authors:  JoAnn Lindenfeld; Nancy M Albert; John P Boehmer; Sean P Collins; Justin A Ezekowitz; Michael M Givertz; Stuart D Katz; Marc Klapholz; Debra K Moser; Joseph G Rogers; Randall C Starling; William G Stevenson; W H Wilson Tang; John R Teerlink; Mary N Walsh
Journal:  J Card Fail       Date:  2010-06       Impact factor: 5.712

9.  Comparison of medical therapy dosing in outpatients cared for in cardiology practices with heart failure and reduced ejection fraction with and without device therapy: report from IMPROVE HF.

Authors:  J Thomas Heywood; Gregg C Fonarow; Clyde W Yancy; Nancy M Albert; Anne B Curtis; Mihai Gheorghiade; Patches Johnson Inge; Mark L McBride; Mandeep R Mehra; Christopher M O'Connor; Dwight Reynolds; Mary Norine Walsh
Journal:  Circ Heart Fail       Date:  2010-07-15       Impact factor: 8.790

10.  Variation in medication adherence in heart failure.

Authors:  Yuting Zhang; Shang-Hua Wu; A Mark Fendrick; Katherine Baicker
Journal:  JAMA Intern Med       Date:  2013-03-25       Impact factor: 21.873
View more
  2 in total

Review 1.  Racial and ethnic disparities in heart failure: current state and future directions.

Authors:  Sabra C Lewsey; Khadijah Breathett
Journal:  Curr Opin Cardiol       Date:  2021-05-01       Impact factor: 2.108

2.  Evaluation of a guideline directed medical therapy titration program in patients with heart failure with reduced ejection fraction.

Authors:  Kathir Balakumaran; Aadhar Patil; Shannon Marsh; Joseph Ingrassia; Chia-Ling Kuo; Daniel Louis Jacoby; Sabeena Arora; Richard Soucier
Journal:  Int J Cardiol Heart Vasc       Date:  2018-11-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.